Suchergebnisse - "Neoplasms mortality"

Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: should we treat beyond two years?

Autoren: Decruyenaere, Alexander Gennigens, Christine Sylvie, Rottey et al.

Weitere Verfasser: Decruyenaere, Alexander Gennigens, Christine Sylvie, Rottey et al.

Quelle: Acta Oncologica, Vol 64 (2025)
Acta oncologica
ACTA ONCOLOGICA

Schlagwörter: Male, Immune Checkpoint Inhibitors/administration & dosage, Radiology, Nuclear Medicine and Imaging, Time Factors, Oncologie, THERAPY, Carcinoma, Renal Cell/secondary, immune checkpoint inhibitors, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Ipilimumab/administration & dosage, Human health sciences, Kidney Neoplasms/mortality, Immune Checkpoint Inhibitors, RC254-282, Aged, 80 and over, OUTCOMES, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Carcinoma, Renal Cell/pathology, Hematology, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Kidney Neoplasms, Progression-Free Survival, Renal cell carcinoma, Nivolumab/administration & dosage, treatment discontinuation, Carcinoma, Renal Cell/mortality, Kidney Neoplasms/drug therapy, Nivolumab, optimal treatment duration, Oncology, Female, Life Sciences & Biomedicine, Adult, DISCONTINUATION, Sciences de la santé humaine, Kidney Neoplasms/pathology, Immune Checkpoint Inhibitors/adverse effects, 3211 Oncology and carcinogenesis, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Carcinoma, Renal Cell, Retrospective Studies, Aged, Science & Technology, Duration of Therapy, Immune Checkpoint Inhibitors/therapeutic use, Ipilimumab, MELANOMA PATIENTS, Carcinoma, Renal Cell/drug therapy, Human medicine, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Follow-Up Studies

Dateibeschreibung: application/pdf

Zugangs-URL: https://doaj.org/article/f0b66be9934249d38e034df42f696b62
https://hdl.handle.net/2268/335276
https://doi.org/10.2340/1651-226X.2025.43876
https://repository.uantwerpen.be/docstore/d:irua:30312
https://hdl.handle.net/10067/2161490151162165141
http://hdl.handle.net/1942/46632
http://hdl.handle.net/1854/LU-01K3QQRTE94KZYP1CX1X0WZ5CD
https://biblio.ugent.be/publication/01K3QQRTE94KZYP1CX1X0WZ5CD/file/01K42SV66F3YD38FGWT899GJ86
https://biblio.ugent.be/publication/01K3QQRTE94KZYP1CX1X0WZ5CD
http://doi.org/10.2340/1651-226x.2025.43876

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Autoren: Uppaluri, Ravindra Haddad, Robert I Tao, Yungan et al.

Quelle: New England Journal of Medicine. 393:37-50

Schlagwörter: Adult, Male, Antibodies, Monoclonal, Humanized / adverse effects, Antibodies, Monoclonal, Humanized / administration & dosage, Young Adult, Chemotherapy, Adjuvant / methods, B7-H1 Antigen / analysis, B7-H1 Antigen / antagonists & inhibitors, Humans, Neoadjuvant Therapy / adverse effects, Antineoplastic Agents, Immunological / administration & dosage, Antineoplastic Agents, Immunological / adverse effects, Aged, Aged, 80 and over, Head and Neck Neoplasms / mortality, Head and Neck Neoplasms / pathology, Squamous Cell Carcinoma of Head and Neck / pathology, Middle Aged, Head and Neck Neoplasms / drug therapy, Neoadjuvant Therapy / methods, Progression-Free Survival, Squamous Cell Carcinoma of Head and Neck / surgery, Intention to Treat Analysis, B7-H1 Antigen / metabolism, Treatment Outcome, Head and Neck Neoplasms / surgery, Squamous Cell Carcinoma of Head and Neck / drug therapy, Female, Chemotherapy, Adjuvant / adverse effects, Squamous Cell Carcinoma of Head and Neck / mortality

Dateibeschreibung: application/pdf

European cancer mortality predictions for the year 2025 with focus on breast cancer

Autoren: C. Santucci S. Mignozzi F. Levi et al.

Quelle: Annals of oncology, vol. 36, no. 4, pp. 460-468

Schlagwörter: Male, Adult, Breast Neoplasms, cancer mortality, predictions, breast cancer, European Union, UK, Middle Aged, Europe, Humans, Female, Breast Neoplasms/mortality, Breast Neoplasms/epidemiology, Europe/epidemiology, Aged, European Union/statistics & numerical data, Mortality/trends, Neoplasms/mortality, Neoplasms/epidemiology, Neoplasms, Mortality

Dateibeschreibung: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40074664
https://hdl.handle.net/2434/1153545
https://doi.org/10.1016/j.annonc.2025.01.014
https://serval.unil.ch/notice/serval:BIB_5D6E051C54CE
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_5D6E051C54CE6
https://serval.unil.ch/resource/serval:BIB_5D6E051C54CE.P001/REF.pdf
https://www.sciencedirect.com/science/article/pii/S0923753425000225
https://doi.org/10.1016/j.annonc.2025.01.014
https://hdl.handle.net/11585/1008875

Multimodal integration of longitudinal noninvasive diagnostics for survival prediction in immunotherapy using deep learning

Autoren: Melda Yeghaian Zuhir Bodalal Daan van den Broek et al.

Quelle: J Am Med Inform Assoc
Jamia. Journal of the American Medical Informatics Association, 32, 8, pp. 1267-1275
Journal of the American Medical Informatics Association, vol. 32, no. 8, pp. 1267-1275

Schlagwörter: FOS: Computer and information sciences, Computer Science - Machine Learning, Computer Science - Artificial Intelligence, longitudinal study, deep learning, Cognitive artificial intelligence, artificial intelligence, Research and Applications, Quantitative Biology - Quantitative Methods, Machine Learning (cs.LG), Artificial Intelligence (cs.AI), FOS: Biological sciences, multimodal data integration, immunotherapy, Humans, Deep Learning, Immunotherapy, Neoplasms/mortality, Neoplasms/therapy, Prognosis, Neural Networks, Computer, Male, Female, Quantitative Methods (q-bio.QM)

Dateibeschreibung: application/pdf

Zugangs-URL: http://arxiv.org/abs/2411.18253
https://cris.maastrichtuniversity.nl/en/publications/f4652115-db49-4ffb-bbd0-43ce79af8e4a
https://doi.org/10.1093/jamia/ocaf074
https://hdl.handle.net/2066/312797
https://repository.ubn.ru.nl//bitstream/handle/2066/312797/312797.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C9F310DE15E50
https://serval.unil.ch/notice/serval:BIB_C9F310DE15E5
https://serval.unil.ch/resource/serval:BIB_C9F310DE15E5.P001/REF.pdf

Tumor-Infiltrating Clonal Hematopoiesis

Autoren: Oriol Pich Elsa Bernard Maria Zagorulya et al.

Quelle: N Engl J Med
The New England journal of medicine, vol. 392, no. 16, pp. 1594-1608

Schlagwörter: Male, Lung Neoplasms, Middle Aged, Article, Monocytes, Dioxygenases, DNA-Binding Proteins, Mice, Observational Studies as Topic, Cell Movement, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Mutation, Tumor Microenvironment, Animals, Humans, Female, Prospective Studies, Clonal Hematopoiesis, Neoplasm Recurrence, Local, Aged, Carcinoma, Non-Small-Cell Lung/genetics, Carcinoma, Non-Small-Cell Lung/immunology, Carcinoma, Non-Small-Cell Lung/mortality, Carcinoma, Non-Small-Cell Lung/pathology, Clonal Hematopoiesis/genetics, Clonal Hematopoiesis/immunology, Dioxygenases/genetics, DNA-Binding Proteins/genetics, Lung Neoplasms/genetics, Lung Neoplasms/mortality, Lung Neoplasms/pathology, Neoplasm Recurrence, Local/epidemiology, Neoplasm Recurrence, Local/genetics, Neoplasm Recurrence, Local/pathology, Tumor Microenvironment/immunology, Monocytes/immunology, Monocytes/pathology, Cell Movement/genetics, Cell Movement/immunology, Neoplasm Transplantation

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40267425
https://ora.ox.ac.uk/objects/uuid:e20d5bce-3d87-4ac2-9e89-b887ca4cc72b
https://doi.org/10.1056/nejmoa2413361
https://serval.unil.ch/notice/serval:BIB_435B0ABCF518
https://serval.unil.ch/resource/serval:BIB_435B0ABCF518.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_435B0ABCF5187

Survival Without Quality of Life Deterioration in the GORTEC 2014-04 'OMET' Randomized Phase 2 Trial in Patients with Head and Neck Cancer with Oligometastases using Stereotactic Ablative Radiation Therapy (SABR) alone or Chemotherapy and SABR

Autoren: Juliette Thariat Mathieu Bosset Antoine Falcoz et al.

Weitere Verfasser: Juliette Thariat Mathieu Bosset Antoine Falcoz et al.

Quelle: International journal of radiation oncology, biology, physics, vol. 121, no. 5, pp. 1194-1206

Schlagwörter: Humans, Quality of Life, Radiosurgery/methods, Radiosurgery/mortality, Male, Female, Middle Aged, Head and Neck Neoplasms/mortality, Head and Neck Neoplasms/pathology, Head and Neck Neoplasms/therapy, Head and Neck Neoplasms/radiotherapy, Head and Neck Neoplasms/drug therapy, Aged, Neoplasm Metastasis, Cetuximab/administration & dosage, Cetuximab/therapeutic use, Fluorouracil/administration & dosage, Squamous Cell Carcinoma of Head and Neck/mortality, Squamous Cell Carcinoma of Head and Neck/therapy, Squamous Cell Carcinoma of Head and Neck/secondary, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Adult, Survival Rate

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39612953
https://serval.unil.ch/resource/serval:BIB_F3A45574859E.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F3A45574859E1
https://serval.unil.ch/notice/serval:BIB_F3A45574859E

Lymphocyte-C-Reactive Protein Ratio: Impact on Prognosis of Patients Following Resection of Primary Liver Cancer.

Autoren: Altaf, Abdullah Baldo, Andrea Khalil, Mujtaba et al.

Weitere Verfasser: Altaf, Abdullah Baldo, Andrea Khalil, Mujtaba et al.

Schlagwörter: HCC CIR, Aged, Middle Aged, Female, Male, Humans, Bile Duct Neoplasms* / blood, Bile Duct Neoplasms* / mortality, Bile Duct Neoplasms* / surgery, Biomarkers, Tumor / blood, C-Reactive Protein* / analysis, C-Reactive Protein* / metabolism, Carcinoma, Hepatocellular* / blood, Hepatocellular* / mortality, Hepatocellular* / surgery, Cholangiocarcinoma* / blood, Cholangiocarcinoma* / mortality, Cholangiocarcinoma* / surgery, Hepatectomy, Liver Neoplasms* / blood, Liver Neoplasms* / mortality, Liver Neoplasms* / surgery, Lymphocytes, Postoperative Complications / epidemiology, Prognosis, Retrospective Studies

Dateibeschreibung: application/pdf

Verfügbarkeit: http://hdl.handle.net/10400.17/5232

Joint Associations of Sedentary Time and Intensity-Specific Physical Activity With Cancer Mortality: A Device-Based Cohort Study of 72,458 UK Adults: A Device-Based Cohort Study of 72,458 UK Adults

Autoren: Leandro F.M. Rezende Matthew Ahmadi Gerson Ferrari et al.

Quelle: ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)

Schlagwörter: Male, Adult, Time Factors, exercise, United Kingdom/epidemiology, neoplasms, Deporte, Middle Aged, United Kingdom, sedentary behavior, Neoplasms, Accelerometry, Sedentarismo, Humans, epidemiology, Female, Neoplasms/mortality, Prospective Studies, Sedentary Behavior, Exercise, Aged, Proportional Hazards Models

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39798552
http://hdl.handle.net/11268/14149

Development of a Decision Model to Estimate the Outcomes of Treatment Sequences in Advanced Melanoma

Autoren: Saskia de Groot Hedwig M. Blommestein Brenda Leeneman et al.

Weitere Verfasser: Saskia de Groot Hedwig M. Blommestein Brenda Leeneman et al.

Quelle: Med Decis Making
Medical Decision Making, 45, 3, pp. 302-317

Schlagwörter: Proto-Oncogene Proteins B-raf, Decision Support Techniques, COST-EFFECTIVENESS, SDG 3 - Good Health and Well-being, Original Research Articles, Proto-Oncogene Proteins B-raf/genetics, Journal Article, BRAF plus MEK inhibitors, METASTATIC MELANOMA, Humans, Melanoma/drug therapy, Skin Neoplasms/mortality, Medical Oncology - Radboud University Medical Center, Melanoma, treatment sequences, immunotherapies, Advanced melanoma, Prognosis, Markov Chains, Treatment Outcome, Mutation, SURVIVAL, Disease Progression, decision model, semi-Markov, REAL-WORLD

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39985400
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/317779
https://doi.org/10.1177/0272989X251319338
https://pure.eur.nl/en/publications/d251aa20-b9d9-4558-8a6d-1e3132efcf5f
https://doi.org/10.1177/0272989X251319338
https://research.rug.nl/en/publications/78b43b9d-b315-43b7-860a-00f5bf5a2ef7
https://hdl.handle.net/11370/78b43b9d-b315-43b7-860a-00f5bf5a2ef7
https://doi.org/10.1177/0272989X251319338
https://cris.maastrichtuniversity.nl/en/publications/dec7d975-1de4-4147-b028-58c982e4f704
https://doi.org/10.1177/0272989X251319338
https://dspace.library.uu.nl/handle/1874/461022
https://hdl.handle.net/2066/317779
https://repository.ubn.ru.nl//bitstream/handle/2066/317779/317779.pdf

Body composition and checkpoint inhibitor treatment outcomes in advanced melanoma: a multicenter cohort study

Autoren: Mark Schuiveling Laurens S Ter Maat Isabella A J Van Duin et al.

Quelle: J Natl Cancer Inst
Journal of the National Cancer Institute, 117, 6, pp. 1245-1252
Journal of the National Cancer Institute, vol. 117, no. 6, pp. 1245-1252

Schlagwörter: Humans, Melanoma/drug therapy, Melanoma/mortality, Melanoma/pathology, Male, Female, Immune Checkpoint Inhibitors/therapeutic use, Body Composition, Middle Aged, Aged, Body Mass Index, Retrospective Studies, Tomography, X-Ray Computed, Adult, Treatment Outcome, Progression-Free Survival, Aged, 80 and over, Netherlands/epidemiology, Skin Neoplasms/drug therapy, Skin Neoplasms/mortality, Skin Neoplasms/pathology, Intra-Abdominal Fat, Muscle, Skeletal/diagnostic imaging, Subcutaneous Fat, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Medical Oncology - Radboud University Medical Center, Article

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39980388
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/320183
https://doi.org/10.1093/jnci/djaf039
https://repository.ubn.ru.nl//bitstream/handle/2066/320183/320183.pdf
https://hdl.handle.net/2066/320183
https://serval.unil.ch/notice/serval:BIB_3415CBA985BE
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3415CBA985BE8
https://serval.unil.ch/resource/serval:BIB_3415CBA985BE.P001/REF.pdf

Evaluating the benefits of immunotherapy in metastatic cervical cancer: an observational retrospective analysis

Autoren: Ana Isabel Martín-Quesada Lina Pérez-Mendez Natalia Dolores Pérez-Rodríguez

Quelle: Clin Transl Oncol
Clinical & translational oncology, vol. 27, no. 8, pp. 3535-3542

Schlagwörter: Brief Research Article, Humans, Female, Uterine Cervical Neoplasms/pathology, Uterine Cervical Neoplasms/drug therapy, Uterine Cervical Neoplasms/mortality, Uterine Cervical Neoplasms/therapy, Retrospective Studies, Middle Aged, Aged, Immunotherapy/methods, Adult, Progression-Free Survival, Antibodies, Monoclonal, Humanized/therapeutic use, Longitudinal Studies, B7-H1 Antigen/analysis, Immune Checkpoint Inhibitors/therapeutic use, Aged, 80 and over, Antineoplastic Agents, Immunological/therapeutic use, Cervical Cancer, Immunotherapy, Metastatic, Objective-Response-Rate, Progression-Free-Survival, Real-World-Evidence, Recurrent

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39921802
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F9D31B2ABC881
https://serval.unil.ch/resource/serval:BIB_F9D31B2ABC88.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F9D31B2ABC88

Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX

Autoren: Rompen I. F. Stoop T. F. Van Roessel S. et al.

Weitere Verfasser: Rompen I. F. Stoop T. F. Van Roessel S. et al.

Quelle: Ann Surg

Schlagwörter: neoadjuvant treatment, Male, Adult, adjuvant chemotherapy, FOLFIRINOX, Pancreatic neoplasm, prognostic score, Oxaliplatin/therapeutic use, Irinotecan/therapeutic use, Surgery, anesthesiology, intensive care, radiology, Leucovorin, Fluorouracil/therapeutic use, Irinotecan, Risk Assessment, Pancreatectomy, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Pancreatic Neoplasms/mortality, Humans, Adjuvant, Retrospective Studies, Aged, Cancer och onkologi, Leucovorin/therapeutic use, Pancreatic Ductal/mortality, Kirurgi, Carcinoma, pancreatic neoplasm, Original Articles, Middle Aged, Prognosis, Neoadjuvant Therapy, Pancreatic Neoplasms, Oxaliplatin, Survival Rate, Chemotherapy, Adjuvant, Cancer and Oncology, Surgery, Female, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil, Carcinoma, Pancreatic Ductal

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39886770
http://hdl.handle.net/10138/597981
https://portal.findresearcher.sdu.dk/da/publications/bbb05d5b-17d2-4f47-bbed-9c352fb42524
https://doi.org/10.1097/SLA.0000000000006650
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-235837

A Quasi-experimental Study of General Practices’ Referral to Mammography in the Posttrial Treatment Era

Autoren: Mette Lise Lousdal Timothy L. Lash W. Dana Flanders et al.

Quelle: Lousdal, M L, Lash, T L, Flanders, W D, Brookhart, M A, Kristiansen, I S, Vedsted, P & Støvring, H 2025, 'A Quasi-experimental Study of General Practices' Referral to Mammography in the Posttrial Treatment Era', Epidemiology, vol. 36, no. 3, pp. 401-407. https://doi.org/10.1097/EDE.0000000000001841

Schlagwörter: Epidemiologic, Denmark, General Practice, Breast Neoplasms, Middle Aged, Confounding Factors, Cohort Studies, Risk Factors, Epidemiology/methods, Humans, Female, Breast neoplasms/mortality, Breast neoplasms/prevention and control, Referral and Consultation, Early Detection of Cancer, Mammography, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39855264

Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab–Based Treatment in Patients With Metastatic NSCLC and Tumor Programmed Death-Ligand 1 Lower Than 1%: A Pooled Analysis

Autoren: Peters, Solange Paz-Ares, Luis G. Reck, Martin et al.

Weitere Verfasser: Peters, Solange Paz-Ares, Luis G. Reck, Martin et al.

Quelle: Digital.CSIC. Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
Journal of thoracic oncology, vol. 20, no. 1, pp. 94-108

Schlagwörter: PD-L1, Nivolumab, Non–small cell lung cancer, Humans, Nivolumab/pharmacology, Nivolumab/therapeutic use, Nivolumab/administration & dosage, Carcinoma, Non-Small-Cell Lung/drug therapy, Carcinoma, Non-Small-Cell Lung/pathology, Carcinoma, Non-Small-Cell Lung/mortality, Lung Neoplasms/drug therapy, Lung Neoplasms/pathology, Lung Neoplasms/mortality, Lung Neoplasms/metabolism, Ipilimumab/pharmacology, Ipilimumab/therapeutic use, Ipilimumab/administration & dosage, Male, Female, Middle Aged, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, B7-H1 Antigen/metabolism, Aged, Adult, Survival Rate, Aged, 80 and over, Follow-Up Studies, Immunotherapy, Ipilimumab

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39369790
http://hdl.handle.net/10261/390933
https://api.elsevier.com/content/abstract/scopus_id/85208360083
https://serval.unil.ch/resource/serval:BIB_89D370D6F09D.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_89D370D6F09D
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_89D370D6F09D7

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes From the Phase 3 POSEIDON Trial

Autoren: Peters, S. Cho, B.C. Luft, A.V. et al.

Quelle: Journal of thoracic oncology, vol. 20, no. 1, pp. 76-93

Schlagwörter: Male, Adult, Humans, Carcinoma, Non-Small-Cell Lung/drug therapy, Carcinoma, Non-Small-Cell Lung/pathology, Carcinoma, Non-Small-Cell Lung/mortality, Lung Neoplasms/drug therapy, Lung Neoplasms/pathology, Lung Neoplasms/mortality, Antibodies, Monoclonal, Humanized/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antibodies, Monoclonal/therapeutic use, Female, Middle Aged, Aged, Survival Rate, Follow-Up Studies, Neoplasm Metastasis, Durvalumab, Five-year overall survival, Metastatic NSCLC, POSEIDON, Tremelimumab, Lung Neoplasms, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39243945
https://serval.unil.ch/resource/serval:BIB_9D803F1B2F65.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_9D803F1B2F658
https://serval.unil.ch/notice/serval:BIB_9D803F1B2F65

TTF-1 negativity in synchronous M1b/M1c wildtype lung adenocarcinoma brain metastases predicts worse survival with increased risk of intracranial progression

Autoren: Wasilewski, David Araceli, Tommaso Bischoff, Philip et al.

Quelle: J Neurooncol

Schlagwörter: 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, Research, Disease Progression [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], TTF-1, Adenocarcinoma of Lung/surgery [MeSH], Survival, Male [MeSH], Brain Neoplasms/mortality [MeSH], Brain Metastasis, Ki67, Edema volume, LUAD, Female [MeSH], Lung Neoplasms/mortality [MeSH], Follow-Up Studies [MeSH], Brain Neoplasms/secondary [MeSH], Adult [MeSH], Humans [MeSH], Tumor volume, Retrospective Studies [MeSH], Middle Aged [MeSH], Adenocarcinoma of Lung/metabolism [MeSH], Survival Rate [MeSH], Biomarkers, Tumor/metabolism [MeSH], Adenocarcinoma of Lung/mortality [MeSH], Prognosis [MeSH], Lung Neoplasms/pathology [MeSH], Lung Neoplasms/metabolism [MeSH], Adenocarcinoma of Lung/pathology [MeSH], Brain Neoplasms/metabolism [MeSH], Thyroid Nuclear Factor 1/metabolism [MeSH]

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39630375
https://repository.publisso.de/resource/frl:6499899

Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP Dynamics.

Autoren: Akabane, Miho Kawashima, Jun Altaf, Abdullah et al.

Weitere Verfasser: Akabane, Miho Kawashima, Jun Altaf, Abdullah et al.

Schlagwörter: HCC CIR, Aged, Female, Male, Humans, Middle Aged, Biomarkers, Tumor, Carcinoma, Hepatocellular* / blood, Hepatocellular* / mortality, Hepatocellular* / pathology, Hepatocellular* / surgery, Follow-Up Studies, Hepatectomy* / mortality, Liver Neoplasms* / blood, Liver Neoplasms* / mortality, Liver Neoplasms* / pathology, Liver Neoplasms* / surgery, Neoplasm Recurrence, Local* / blood, Local* / metabolism, Local* / mortality, Local* / pathology, Local* / surgery, Retrospective Studies, Prognosis, Survival Rate, Tumor Burden, alpha-Fetoproteins* / metabolism

Dateibeschreibung: application/pdf

Verfügbarkeit: http://hdl.handle.net/10400.17/5157

Loss of Skeletal Muscle Mass Is Associated With Reduced Cytotoxic T Cell Abundance and Poor Survival in Advanced Lung Cancer

Autoren: Xin Nie Yan Sun David P. J. van Dijk et al.

Quelle: Journal of Cachexia, Sarcopenia and Muscle. 16

Schlagwörter: Male, Sarcopenia, T-Lymphocytes, skeletal muscle mass, Middle Aged, survival, lung cancer, Cytotoxic/immunology, Skeletal/pathology, Body Composition, Humans, Muscle, Female, Lymphocytes, Tumor-Infiltrating, Lung Neoplasms/mortality pathology complications immunology, TILs, cytotoxic T cell, Aged

Zugangs-URL: https://cris.maastrichtuniversity.nl/en/publications/a05955c2-5630-40ec-93c5-56520e0a84b7
https://doi.org/10.1002/jcsm.70063

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results

Autoren: J. Rubio‐Briones A. Borque‐Fernando L. M. Esteban Escaño et al.

Quelle: Zaguán. Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza

Schlagwörter: Aged, 80 and over, Male, Persona de Mediana Edad, Anciano, España, Prostatic Neoplasms, Neoplasias de la Próstata, Middle Aged, Estudios Longitudinales, Sistema de Registros, Magnetic Resonance Imaging, Anciano de 80 o más Años, Humanos, Spain, Humans, Aged Aged, 80 and over Humans Longitudinal Studies Magnetic Resonance Imaging Male Middle Aged Prostatic Neoplasms* / diagnosis Prostatic Neoplasms* / epidemiology Prostatic Neoplasms* / mortality Prostatic Neoplasms* / pathology Prostatic Neoplasms* / therapy Registries Spain / epidemiology Watchful Waiting* / statistics & numerical data, Longitudinal Studies, Registries, Espera Vigilante, Watchful Waiting, Masculino, Imagen por Resonancia Magnética, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: http://zaguan.unizar.es/record/162740
https://hdl.handle.net/20.500.13003/25885

Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial

Autoren: Gros, L. Bouattour, M. Dumont, C. et al.

Quelle: Liver international, vol. 45, no. 8, pp. e70196

Schlagwörter: Humans, Sunitinib/therapeutic use, Sunitinib/adverse effects, Sunitinib/blood, Male, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/mortality, Cholangiocarcinoma/pathology, Female, Middle Aged, Aged, Bile Duct Neoplasms/drug therapy, Bile Duct Neoplasms/mortality, Bile Duct Neoplasms/pathology, France, Angiogenesis Inhibitors/therapeutic use, Angiogenesis Inhibitors/adverse effects, Progression-Free Survival, Adult, Vascular Endothelial Growth Factor A/blood, Aged, 80 and over, Antineoplastic Agents/therapeutic use, Antineoplastic Agents/adverse effects, Choi criteria, VEGF, angiogenesis inhibitors, biliary tract cancer, tumour density

Dateibeschreibung: application/pdf

Zugangs-URL: https://serval.unil.ch/resource/serval:BIB_F135E275450F.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F135E275450F
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F135E275450F5